Literature DB >> 24402462

Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties.

Wasfy M Obeidat1, Al-Sayed A Sallam.   

Abstract

The aim of this work was to prepare and evaluate Tadalafil nanosuspensions and their PEG 4000 solid dispersion matrices to enhance its dissolution rate. Nanosuspensions were prepared by precipitation/ultrasonication technique at 5°C where different stabilizers were screened for stabilization. Nanosuspensions were characterized in terms of particle size and charge. Screening process limited suitable stabilizers into structurally related surfactants composed of a mixture of Tween80 and Span80 at 1:1 ratio (in percent, weight/volume) in adjusted alkaline pH (named TDTSp-OH). The surfactant mixture aided the production of nanosuspensions with an average particle size of 193 ± 8 nm and with short-term stability sufficient for further processing. Solid dispersion matrices made of dried Tadalafil nanosuspensions or dried Tadalafil raw powder suspensions and PEG 4000 as a carrier were prepared by direct compression. Drying was performed via dry heat or via freeze dry. Drug release studies showed that, in general, tablet formulations made of freeze-dried product exhibited faster initial release rates than the corresponding tablets made of oven-dried products which could be attributed to possible larger crystal growth and larger crushing strengths of oven-dried formulations. At best, 60% of drug was released from solid dispersion matrices, while more than 90% of drug was released from TDTSp-OH nanosuspension within the first 5 min. In conclusion, Tadalafil nanosuspensions obtained using a mixed surfactant system provided rapid dissolution rates of Tadalafil that can theoretically enhance its bioavailability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402462      PMCID: PMC3969483          DOI: 10.1208/s12249-013-0070-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

Review 1.  In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.

Authors:  J B Dressman; C Reppas
Journal:  Eur J Pharm Sci       Date:  2000-10       Impact factor: 4.384

Review 2.  Nanosuspensions: a promising drug delivery strategy.

Authors:  V B Patravale; Abhijit A Date; R M Kulkarni
Journal:  J Pharm Pharmacol       Date:  2004-07       Impact factor: 3.765

Review 3.  Nanosuspensions in drug delivery.

Authors:  Barrett E Rabinow
Journal:  Nat Rev Drug Discov       Date:  2004-09       Impact factor: 84.694

Review 4.  The role of the medicinal chemist in drug discovery--then and now.

Authors:  Joseph G Lombardino; John A Lowe
Journal:  Nat Rev Drug Discov       Date:  2004-10       Impact factor: 84.694

5.  Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.

Authors:  Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab; Ahmed S Zidan
Journal:  AAPS PharmSciTech       Date:  2006-06-16       Impact factor: 3.246

6.  Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.

Authors:  S M Wong; I W Kellaway; S Murdan
Journal:  Int J Pharm       Date:  2006-05-02       Impact factor: 5.875

7.  Crystallization of glycine with ultrasound.

Authors:  Marjatta Louhi-Kultanen; Milja Karjalainen; Jukka Rantanen; Mikko Huhtanen; Juha Kallas
Journal:  Int J Pharm       Date:  2006-05-03       Impact factor: 5.875

8.  Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.

Authors:  P Kocbek; S Baumgartner; J Kristl
Journal:  Int J Pharm       Date:  2006-02-15       Impact factor: 5.875

Review 9.  Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

Authors:  Cornelia M Keck; Rainer H Müller
Journal:  Eur J Pharm Biopharm       Date:  2005-08-29       Impact factor: 5.571

10.  Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial.

Authors:  Hartmut Porst; Harin Padma-Nathan; François Giuliano; Greg Anglin; Lucio Varanese; Raymond Rosen
Journal:  Urology       Date:  2003-07       Impact factor: 2.649

View more
  3 in total

Review 1.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

2.  Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats.

Authors:  Mohammed Muqtader Ahmed; Md Khalid Anwer; Gamal A Soliman; Mohammed F Aldawsari; Abdul Aleem Mohammed; Sultan Alshehri; Mohammed M Ghoneim; Amer S Alali; Abdullah Alshetaili; Ahmed Alalaiwe; Sarah I Bukhari; Ameeduzzafar Zafar
Journal:  PeerJ       Date:  2022-05-26       Impact factor: 3.061

3.  Bioenhanced advanced third generation solid dispersion of tadalafil: Repurposing with improved therapy in pyelonephritis.

Authors:  Prashant P Mande; Sagar S Bachhav; Padma V Devarajan
Journal:  Asian J Pharm Sci       Date:  2017-08-03       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.